We are live on
!
Find out more
WCM
Wildcat Capital Management Portfolio holdings
AUM
$229M
1-Year Est. Return
132.65%
This Fund
S&P 500
This Quarter
Est. Return
-1.64%
1 Year Est. Return
+132.65%
3 Year Est. Return
+125.67%
5 Year Est. Return
+54.1%
10 Year Est. Return
+1,929.91%
AUM
$819M
AUM Growth
+$23.1M
(+2.9%)
Cap. Flow
+$66.7M
Cap. Flow
% of AUM
8.15%
Top 10 Holdings %
Top 10 Hldgs %
87.61%
Holding
33
New
7
Increased
4
Reduced
5
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RLX Technology
RLX
|
+$16M |
| 2 |
Coupang
CPNG
|
+$13.2M |
| 3 |
Snowflake
SNOW
|
+$11.4M |
| 4 |
DoorDash
DASH
|
+$10.9M |
| 5 |
T-Mobile US
TMUS
|
+$9.45M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UroGen Pharma
URGN
|
+$15.3M |
| 2 |
FIRY
Firy Inc
FIRY
|
+$4.8M |
| 3 |
CoStar Group
CSGP
|
+$4.77M |
| 4 |
Magnolia Oil & Gas
MGY
|
+$1.25M |
| 5 |
UROV
Urovant Sciences Ltd.
UROV
|
+$1.05M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 59.21% |
| 2 | Healthcare | 13.39% |
| 3 | Consumer Discretionary | 11.32% |
| 4 | Real Estate | 7.02% |
| 5 | Financials | 3.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FIRY
1
Firy Inc
FIRY
$148M
| $405M | 49.45% |
1,063,291
-8,361
| -0.8% | -$4.8M |
|
|
2
CoStar Group
CSGP
$11.7B
| $57.5M | 7.02% |
699,870
-55,230
| -7% | -$4.77M |
|
3
Allogene Therapeutics
ALLO
$649M
| $53.5M | 6.53% |
1,515,524
| – | – |
|
|
KRON
4
DELISTED
Kronos Bio
KRON
| $42.1M | 5.14% |
1,438,232
| – | – |
|
5
Booking.com
BKNG
$149B
| $33.6M | 4.1% |
360,275
| – | – |
|
6
Meta Platforms (Facebook)
META
$1.42T
| $30.7M | 3.75% |
104,134
| – | – |
|
7
Liberty Broadband Class C
LBRDK
$4.88B
| $29.7M | 3.62% |
197,541
+35,644
| +22% | +$5.39M |
|
8
Goosehead Insurance
GSHD
$2.2B
| $26.5M | 3.24% |
247,627
+34,949
| +16% | +$4.73M |
|
|
9
T-Mobile US
TMUS
$185B
| $19.6M | 2.39% |
156,207
+75,000
| +92% | +$9.45M |
|
10
Planet Fitness
PLNT
$4.42B
| $19.4M | 2.37% |
250,574
| – | – |
|
11
Global Payments
GPN
$23B
| $16.1M | 1.97% |
79,941
| – | – |
|
|
12
Coupang
CPNG
$29.3B
| $14.1M | 1.72% |
+285,714
| New | +$13.2M |
|
13
Accel Entertainment
ACEL
$978M
| $11.6M | 1.41% |
1,059,522
-73,683
| -7% | -$789K |
|
|
14
UroGen Pharma
URGN
$1.86B
| $10.4M | 1.27% |
533,139
-719,146
| -57% | -$15.3M |
|
|
SBR
15
Sabine Royalty Trust
SBR
$1.06B
| $10.1M | 1.23% |
335,564
| – | – |
|
|
16
Snowflake
SNOW
$102B
| $9.8M | 1.2% |
+42,730
| New | +$11.4M |
|
|
17
RLX Technology
RLX
$2.47B
| $8.63M | 1.05% |
+833,300
| New | +$16M |
|
|
18
DoorDash
DASH
$85.5B
| $8.54M | 1.04% |
+65,159
| New | +$10.9M |
|
|
PLYA
19
DELISTED
Playa Hotels & Resorts
PLYA
| $5.54M | 0.68% |
759,488
-66,049
| -8% | -$435K |
|
|
EXAS
20
DELISTED
Exact Sciences
EXAS
| $2.3M | 0.28% |
+17,463
| New | +$2.39M |
|
21
Uber
UBER
$143B
| $2.16M | 0.26% |
39,618
| – | – |
|
22
PUT
iShares S&P 100 ETF
OEF
$20.1B
| $700K | 0.09% |
+111,500
| New | +$19.7M |
|
23
Twist Bioscience
TWST
$5.7B
| $690K | 0.08% |
+5,570
| New | +$846K |
|
|
OYST
24
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $664K | 0.08% |
36,302
| – | – |
|
|
25
CALL
iShares S&P 100 ETF
OEF
$20.1B
| $100K | 0.01% |
34,000
+19,600
| +136% | +$3.46M |
|
Similar funds
AFO
CNHF
GCM
CM
CSIA
AF
NIA
HFA
Wildcat Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, Wildcat Capital Management held 33 positions worth $819M, up 2.9% from $796M the previous quarter. Its ten largest holdings account for 88% of the portfolio.
Wildcat Capital Management deployed $66.7M of net new capital in Q1 2021, opening 7 new positions and adding to 4 existing holdings. Its largest new stake was RLX Technology: 833,300 shares worth $8.63M.
By sector, the portfolio is most concentrated in Communication Services at 59% of assets, down from 62% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was UroGen Pharma, an estimated $15.3M trimmed.
- Wildcat Capital Management's largest Q1 2021 buy was RLX Technology: 833,300 shares worth $8.63M.
- Wildcat Capital Management added most to T-Mobile US in Q1 2021, an estimated $9.45M increase.
- Wildcat Capital Management's biggest Q1 2021 reduction was UroGen Pharma, cutting an estimated $15.3M.
- Wildcat Capital Management fully exited Magnolia Oil & Gas in Q1 2021, selling an estimated $1.25M.
- Wildcat Capital Management's ten largest holdings make up 88% of its $819M portfolio in Q1 2021.
- Wildcat Capital Management opened 7 new positions and closed 8 in Q1 2021.
- Wildcat Capital Management's portfolio value rose 2.9% quarter-over-quarter to $819M.
Based on Wildcat Capital Management's 13F filing for Q1 2021, filed 17 May 2021.